+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Receptor for advanced glycation end-products-mediated inflammation and diabetic vascular complications



Receptor for advanced glycation end-products-mediated inflammation and diabetic vascular complications



Journal of Diabetes Investigation 2(3): 155-157




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055403722

Download citation: RISBibTeXText

PMID: 24843476

DOI: 10.1111/j.2040-1124.2011.00125.x


Related references

Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications. Journal of Diabetes Investigation 3(2): 107-114, 2012

Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications. Therapeutic Apheresis and Dialysis 13(6): 534-539, 2010

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications. Cardiovascular Diabetology 14: 2, 2016

Advanced Glycation End Products (Ages) and Diabetic Vascular Complications. Current Diabetes Reviews 1(1): 93-106, 2005

Advanced glycation end-products and the progress of diabetic vascular complications. Physiological Research 53(2): 131-142, 2004

The Role of Advanced Glycation End Products in Diabetic Vascular Complications. Diabetes and Metabolism Journal 42(3): 188-195, 2018

Advanced glycation end products (AGEs) and diabetic vascular complications. Current Diabetes Reviews 1(1): 93-106, 2008

The role of advanced glycation end-products (AGEs) in the development of vascular diabetic complications. Arquivos Brasileiros de Endocrinologia E Metabologia 52(6): 940-950, 2008

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. Journal of Clinical Investigation 97(1): 238-243, 1996

Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients. Biomed Research International 2017: 7989180, 2018

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care 28(11): 2716-2721, 2005

The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus. Nephrology, Dialysis, Transplantation 11(Suppl. 5): 13-16, 1996

The C-terminal tails of 4,4'-diphenylmethane-bis(methyl) carbamate are essential for binding to receptor for advanced glycation end products to attenuate advanced glycation end products-induced inflammation and apoptosis responses in human umbilical vein endothelial cells. Journal of Pharmacy and Pharmacology 68(1): 93-106, 2016

Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway. Chinese Journal of Natural Medicines 14(11): 844-855, 2017

Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress. Iranian Journal of Medical Sciences 36(3): 154-166, 2011